Skip to content

Waters Corporation WAT Waters Advanced Diagnostics — Operating Income

Similar metrics at other companies

Fortune Brands Innovations logo
FBINWater — Operating Income
$103.7M+0.5%
Restoration Hardware logo
RHWaterworks — Operating Income
$3.62M-31.9%
Ecolab logo
ECLWater Services — Operating Income
$297.8M+6.9%
Danaher logo
DHRDiagnostics — Operating Income (Loss)
$674M-6.1%
Cadiz logo
CDZIWater Treatment — Operating Income
-$795K-955%
Kulicke & Soffa Industries logo
KLICAdvanced Solutions — Operating Income (Loss)
-$5.63M+8.1%

Other financials

Income statement

See full
Revenue$1.3B+91.4%
Gross profit$569.5M+8.6%
Operating income-$47.0M-131%
Net income-$72.0M-160%
EPS (diluted)-$0.87-143%

Balance sheet

See full
Cash & equivalents$462.0M+20.7%
Total debt$5.2B+263%
Total equity$15.3B+679%
Total assets$24.5B+434%

Cash flow

See full
Operating cash flow-$3.0M-101%
CapEx$39.0M+50.0%
Free cash flow-$42.0M-118%

Valuation

See full
Market cap$36.76B+78.1%
Enterprise value$41.51B+92.6%
P/E81.8×+50.6×
P/S9.8×+3.0×

Profitability

See full
Gross margin59.3%-0.1pp
Operating margin16%-12.3pp
Net margin11.9%-10.1pp
FCF margin7%-13.8pp

Returns & leverage

See full
Return on equity5.2%-35.6pp
Debt / equity0.3×-0.4×
Current ratio1.8×0.0×

Where this comes from

Reported directly by Waters Corporation in its filing.

Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.

The official record: Waters Corporation’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Waters Corporation's waters advanced diagnostics — operating income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Waters Corporation's waters advanced diagnostics — operating income?
Waters Corporation (WAT) reported waters advanced diagnostics — operating income of $70M in Q1 2026.
What does waters advanced diagnostics — operating income mean?
Calculated as the segment's revenue minus its direct costs and operating expenses, representing the core profitability of the Advanced Diagnostics business. It excludes interest, taxes, and corporate-level allocations, providing a clear view of segment-specific operational performance.